Strategic Joint Ventures for Clients

Co-conceived and actively led the global restructuring of Hoffmann LaRoche Manufacturing from 1989 to 1994 which included a revision to previously extravagant Materials Management that incorporated high integration and today reflects 14 joint ventures, 5 strategic alliances, 4 divestitures, 1 acquisition, and 3 affiliate technology investments -- one of which included Genentech and others including Laboratory Corporation of America

Advised Roche concerning the value of product-technology alliances with Agouran and Gene Medicine, Inc which were acquired with Syntex